BNET Industries
Last Fiscal Year Sales:$168.0M
- Private
- CA
Dow Jones Description
Atrium Innovations inc. is a leading developer, manufacturer and marketer of value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. The Company focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium Innovations markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 50 countries, primarily in North America, Europe and Asia.
President and Chief Executive Officer
Pierre FitzgibbonNumber of Employees 75
Contact Information
1405 Parc Technologique Blvd
Quebec, Quebec G1P 4P5
(418) 652-1116
Peer Companies
NAICS Code All Other Miscellaneous Chemical Product and Preparation Manufacturing: 325998
News & Analysis
Filter by
atrium biotechnologies inc. - All News and Analysis
AEterna Zentaris to Sell 3,485,000 Subordinate Voting Shares of Atrium Biotechnologies Through Secondary Offering; - AEterna Zentaris to become a pure play biopharmaceutical company focused on endocrine therapy and oncology - AEterna Zentaris intends to c
- 2006-09-19
QUEBEC CITY, QUEBEC, Sep 19, 2006 CCNMatthews via COMTEX -- This release is intended for distribution in Canada only and is not intended for distribution to United States newswire services or for dissemination in the United States. AEterna Zentaris Inc. (TSX:AEZ)(NASDAQ:AEZS), a growing global...
Atrium Biotechnologies.(SUPPLIER NEWS)
- 2006-03-01
Atrium Biotechnologies' cosmetic active ingredients department is now officially part of the company's Active Ingredients & Specialty Chemicals Division.
TA Associates' Portfolio Company Douglas Laboratories Acquired by Atrium Biotechnologies for Approximately $92 Million
- 2005-12-08
BOSTON -- TA Associates, a leading private equity and buyout firm, today announced the sale of a portfolio company, Pittsburgh-based HVL Inc., whose main brand is Douglas Laboratories. Canadian-based Atrium Biotechnologies Inc. (TSX: ATB.sv) acquired Douglas for approximately $92 million. Atrium is a leading developer, manufacturer and marketer of value-added...
Fytokem, Atrium Biotechnologies partner
- 2003-01-01
Fytokem Products, Saskatoon, Saskatchewan, Canada, has entered into an agreement with Atrium Biotechnologies, Quebec City, Canada, to market on an exclusive worldwide basis two of Fytokem's leading product lines for the nutraceutical and personal care markets. The long term cooperation and licensing agreement with Atrium provides Fytokem with a significant...
Atrium adds French cosmetics firm. (Specialties).(Atrium Biotechnologies has acquired ADF Chimie)(Brief Article)
- 2002-05-15
Atrium Biotechnologies Quebec City has acquired ADF Chimie (Poitiers, France), a privately held supplier of active and specialty ingredients to the French cosmetics industry, for C$3 million ($1.9 million). ADF's total sales, to customers including L'Oreal and Chanel, exceeded $5 million last year, Atrium says. The...
Alain Bouchard. (Jobs and People).(appointed at Atrium Biotechnologies Inc.)(Brief Article)
- 2002-04-15
Alain Bouchard has been elected as a member of the board of directors of Atrium Biotechnologies Inc. Mr. Bouchard is currently chairman of the board, president and chief executive officer of Alimentation Couch-Tard Inc.
Atrium Biotechnologies Announces Key Executive Appointments, and the Acquisition of a Product Line.
- 2000-10-03
QUEBEC CITY, Quebec, Oct 03, 2000 Atrium Biotechnologies Inc., private subsidiary of AEterna Laboratories Inc. (TSE: AEL; NASDAQ: AELA), announced today several key executive appointments, as well as the acquisition of a product line in the nutritional supplements market distributed in the United States....
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Pierre Fitzgibbon | President and Chief Executive Officer |
| Yvon Bolduc | President and CEO |
| Jacques Gauthier | Senior Vice President and Coo, Kruger Energy |
| John Dempsey | Vice President, Finance and Chief Financial Officer |
| Mario Paradis | Vice President and Chief Financial Officer |
| Serge Yelle | Executive Vice President, Operations |
| Jocelyn Harvey | Vice President, Mergers and Acquisitions |
| Laboratoires Aeterna | Vice President, Corporate Development |
| Manon Deslauriers | Vice President, Legal and Corporate Affairs |
| Yvan Sergerie | Vice President, Intl Sales & Marketing |
| Paul Burroughs | Director, Communications |
| Caroline Bernard | Investor Relations Coordinator |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Luc Dupont | Chairman of the Executive Committee |
| Pierre Laurin | Chairman of the Board |
| Alain Bouchard | Board of Directors |
| Carole St-Charles | Board of Directors |
| Claude Lamoureux | Board of Directors |
| Gerard Limoges | Board of Directors |
| Placide Poulin | Board of Directors |
| Yves Julien | Board of Directors |
| Yves Juliento | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | President and Chief Executive Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | President and CEO | Current |
| Atrium Biotechnologies Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Senior Vice President and Coo, Kruger Energy | Current |
| Aaer Systems Inc | Executive Vice President and Operations Manager, Kruger, Energy Group, Montreal | Current |
| Aaer Systems Inc | Board of Directors | Current |
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Boralex Inc. | President and Chief Executive Officer | Former |
| Boralex Inc. | Executive Vice President | Former |
| Aaer Systems Inc | Lawyer | Former |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Vice President, Finance and Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Vice President and Chief Financial Officer | Current |
Since January 2002. Prior to joining Atrium Innovations, Dr Yelle was General Manager of the Fonds d'investissement bioalimentaire, s.e.c., part of the Fonds de solidarite des travailleurs du Quebec (F.T.Q.). He was also General Manager of a research centre at Laval University, where he started his career as a professor in plant biology.
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Executive Vice President, Operations | Current |
| Atrium Biotechnologies Inc. | Vice President, Business Development | Former |
| Laval University | General Manager | Former |
| Laval University | Professor | Former |
Since September 2000. Over twenty years experience in accounting and finance as well as in the field of company mergers and acquisitions. Member of the Quebec Order of Chartered Accountants.
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Vice President, Mergers and Acquisitions | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Vice President, Corporate Development | Current |
| Atrium Biotechnologies Inc. | Co-Founder of Les | Former |
Since March 2001. Ms. Deslauriers was in-house counsel with Societe generale de financement du Quebec and SGF Soquia Inc. and Secretary of the latter, from 1997 to 2001. Ms. Deslauriers has been a member of the Quebec Bar since 1990.
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Vice President, Legal and Corporate Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Vice President, Intl Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Director, Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Investor Relations Coordinator | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Chairman of the Executive Committee | Current |
| Atrium Biotechnologies Inc. | President & CEO | Former |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Chairman of the Board | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Atrium Biotechnologies Inc. | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Steelcase Incorporated Q3 2010 Earnings Call Transcript
on Dec 18, 2009about SCS
-
Quiksilver Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 17, 2009about ZQK
-
NIKE, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about NKE
-
Actuant Corp. F1Q10 (Qtr End 11/30/2009) Earnings Call Transcript
on Dec 17, 2009about ATU
-
Apogee Enterprises F3Q10 (Qtr End 11/28/09) Earnings Conference Call Transcript
on Dec 17, 2009about APOG
Glass Door
Manufacturing Industry Companies
| Company | Employer Rating |
| Alcoa |  |
| United Technologies | |
| BAE SYSTEMS (United Kingdom) | |
| Textron |  |
| Boeing | |
IndustryTop Rated
Presented by American Express